Therapeutic options in advanced prostate cancer: Present and future

被引：21
|
作者：
Sowery R.D. [1 ]
So A.I. [1 ]
Gleave M.E. [1 ]
机构：
[1] Prostate Centre, Vancouver General Hospital, Vancouver, BC V5Z1M9
来源：
Current Urology Reports | 2007年 / 8卷 / 1期
关键词：
Prostate Cancer; Docetaxel; Zoledronic Acid; Mitoxantrone; Androgen Deprivation Therapy;
D O I：
10.1007/s11934-007-0021-9
中图分类号：
学科分类号：
摘要：
Patients with advanced prostate cancer now have many treatment options available including first- and second-line hormonal therapy, radiotherapy, bisphosphonate therapy with zoledronic acid, and taxane-based chemotherapy. These options now give clinicians an opportunity to offer their patients symptomatic relief and most importantly improve overall survival. This article reviews the current treatment options available for men with advanced prostate cancer. In addition, novel treatment options under development, including calcitriol, immunotherapies, small molecule inhibitors, and nucleotide-based targeted therapy, are discussed. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码：53 / 59
页数：6
相关论文
共 50 条
  • [1] Therapeutic options in locally defined or advanced prostate cancer
    Altwein, JE
    [J]. EUROPEAN UROLOGY, 1999, 35 : 9 - 15
  • [2] Therapeutic Options for Advanced Prostate Cancer: 2011 Update
    Aurelius Omlin
    Johann S. de Bono
    [J]. Current Urology Reports, 2012, 13 : 170 - 178
  • [3] Therapeutic Options for Advanced Prostate Cancer: 2011 Update
    Omlin, Aurelius
    de Bono, Johann S.
    [J]. CURRENT UROLOGY REPORTS, 2012, 13 (02) : 170 - 178
  • [4] Therapeutic options for localized and locally advanced prostate cancer - Summary
    Jocham, D
    [J]. UROLOGIA INTERNATIONALIS, 1998, 60 : 31 - 32
  • [5] Therapeutic options for localized and locally advanced prostate cancer - Introduction
    Jocham, D
    [J]. UROLOGIA INTERNATIONALIS, 1998, 60 : 1 - 1
  • [6] Therapeutic options in locally defined or advanced prostate cancer - Discussion
    Zerbib, M
    Altwein, JE
    Zip, C
    [J]. EUROPEAN UROLOGY, 1999, 35 : 16 - 16
  • [7] Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma
    Sfoungaristos, Stavros
    Giannitsas, Konstantinos
    Perimenis, Petros
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (04) : 533 - 547
  • [8] Management of locally advanced prostate cancer: Past, present, future
    Swanson, Gregory P.
    [J]. JOURNAL OF UROLOGY, 2006, 176 (06): : S34 - S41
  • [9] Therapeutic Options for Chlamydia trachomatis Infection: Present and Future
    Rodrigues, Rafaela
    Marques, Lara
    Vieira-Baptista, Pedro
    Sousa, Carlos
    Vale, Nuno
    [J]. ANTIBIOTICS-BASEL, 2022, 11 (11):
  • [10] Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer
    Wadosky, Kristine M.
    Koochekpour, Shahriar
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (04): : 409 - 426
12345